Related Experiment Video
Updated: Jun 5, 2026
10:58
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
Abagovomab for ovarian cancer
Jacobus Pfisterer1, Philipp Harter, Cecilia Simonelli
1Klinik für Gyäkologie und Geburtshilfe Städtisches Klinikum Solingen, Gotenstr. 1, 42653 Solingen, Germany.
Expert Opinion on Biological Therapy
|January 19, 2011
Summary
Abagovomab immunotherapy shows promise for ovarian cancer maintenance therapy. It stimulates immune responses and prolonged survival in recurrent cases, with a favorable safety profile.
Area of Science:
- Oncology
- Immunotherapy
- Gynecologic Cancers
Background:
- Ovarian cancer (OC) is a leading cause of cancer death in women.
- Advanced-stage diagnosis is common (>70%), leading to high recurrence rates (>75%) after initial treatment.
- There is a critical need for novel therapeutic strategies for OC.
Purpose of the Study:
- To evaluate abagovomab as a maintenance therapy for advanced ovarian cancer.
- To review the development, mechanism of action, and clinical trial data of abagovomab.
- To assess the potential of abagovomab in improving outcomes for OC patients.
Main Methods:
- Review of abagovomab's development status and immunotherapy role.
- Analysis of abagovomab's generation, mechanism of action, and Phase I/II results.
- Consideration of ongoing Phase II/III trial data for maintenance therapy in advanced OC.
Main Results:
- Abagovomab effectively stimulates both humoral and cell-mediated immune responses.
- A proof-of-concept study demonstrated prolonged overall survival in recurrent OC patients with an immune response.
- Abagovomab exhibits an excellent safety and tolerability profile.
Conclusions:
- Abagovomab is a promising candidate for maintenance treatment in ovarian cancer patients post-frontline therapy.
- Its ability to induce immune responses and prolong survival supports its therapeutic potential.
- Final results from the pivotal Phase II/III study are anticipated in early 2011.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...